| Serial Number | 88482293 |
| Word Mark | RESOLVE-IT |
| Filing Date | Thursday, June 20, 2019 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, August 11, 2020 |
| Registration Number | 6121991 |
| Registration Date | Tuesday, August 11, 2020 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, May 26, 2020 |
| Goods and Services | Pharmaceutical research, namely, research for the discovery of new drugs; scientific research, in particular in the medical, biomedical, chemical, genetic, pharmaceutical or veterinary fields; basic and applied scientific research; technical research in the field of pharmaceutical studies; Scientific and technological services, namely, screening and selecting of pharmaceutical molecules and biomarkers in the field of biopharmaceuticals for medical research purpose; Development and establishment of biological test, cell test and genetic test specifications and procedures in the field of biopharmaceuticals; Scientific and technological services, namely, functional analysis of genomics to identify, characterize, validate or develop biologically active nuclear receptors in the field of biopharmaceuticals; Scientific and technological services, namely, analysis of biological substances in biologic fluids in the field of biopharmaceuticals; Scientific and technological services, namely, conducting clinical trials namely, functional analysis to identify, characterize, validate or develop biologically active pharmaceutical molecules and biomarkers in the field of biopharmaceuticals; Scientific and technological services, namely, conducting clinical trials namely, analysis of biological substances in biologic fluids in the field of biopharmaceuticals; Computer programming in the field of scientific research and for the pharmaceutical industry; Scientific and technological services, namely, analysis in the field of biopharmaceuticals; Technology specification, namely, analyzing technology requirements and developing recommendations for the computer software and systems and other technology needed to meet those requirements, in the field of biopharmaceuticals; Professional consultancy, not connected with the conduct of business, in the fields of scientific research; research and development of new pharmaceutical products for third parties; scientific research in the field of pharmacy |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, July 1, 2019 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | VENTUS THERAPEUTICS U.S., INC. |
| Party Type | 31 - New Owner After Registration |
| Legal Entity Type | 03 - Corporation |
| Address | WALTHAM, MA 02453 |
| Party Name | GENFIT société anonyme (SA) |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Loos 59120 FR |
| Party Name | GENFIT société anonyme (SA) |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Loos 59120 FR |
| Party Name | GENFIT société anonyme (SA) |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Loos 59120 FR |
| Event Date | Event Description |
| Wednesday, September 11, 2019 | ASSIGNED TO EXAMINER |
| Monday, June 24, 2019 | NEW APPLICATION ENTERED |
| Monday, July 1, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, September 17, 2019 | NON-FINAL ACTION WRITTEN |
| Tuesday, September 17, 2019 | NON-FINAL ACTION E-MAILED |
| Tuesday, September 17, 2019 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, March 13, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, March 16, 2020 | TEAS VOLUNTARY AMENDMENT RECEIVED |
| Tuesday, March 24, 2020 | ASSIGNED TO LIE |
| Wednesday, March 25, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, March 25, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, March 26, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, March 26, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, May 6, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, April 21, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, May 26, 2020 | PUBLISHED FOR OPPOSITION |
| Tuesday, May 26, 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, May 28, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, May 28, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Tuesday, May 28, 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Tuesday, May 28, 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Tuesday, May 28, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, May 1, 2024 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Tuesday, August 11, 2020 | REGISTERED-PRINCIPAL REGISTER |